3 Stocks That Should Keep Delivering The Goods: GlaxoSmithKline plc, Lloyds Banking Group PLC & Prudential plc

GlaxoSmithKline plc (LON: GSK), Lloyds Banking Group PLC (LON: LLOY) and Prudential plc (LON: PRU) are stocks to buy and forget, says Harvey Jones

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

If you’re looking for a stock to buy and forget, here are three FTSE 100 stalwarts that should deliver long-term dividends and growth.

Lloyds Is Back

Normality is slowly returning to Lloyds Banking Group (LSE: LLOY) (NYSE: LYG.US), with suggestions that it could be paying dividends and 100% in private ownership within the year.

Lloyds is the ‘back to the future’ bank, as it returns to what it knows best, serving the UK retail market and rewarding loyal investors with lashings of juicy dividends.

True, the UK isn’t exactly booming, with the Bank of England downgrading 2015 GDP growth from 2.9% to 2.5%, with similar revisions to expectations in 2016 and beyond.

But at least Lloyds is a known entity, and one that is forecast to yield 4.8% by the end of 2016.

Trading at 11 times earnings it looks a decent buy with a solid, if unspectacular, future. After the troubles of recent years, that is good enough for me.

Glaxo Will Go

News that GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) is guaranteeing its dividend for three years was welcomed by the market, which feared the payout would be come under pressure due to falling earnings.

Glaxo has walked a rocky road lately, with worries over the Chinese bribery scandal superseded by fears over falling profits, but chief executive Sir Andrew Witty expects sales growth next year.

Trading at nearly 15% below its 52-week high of 1,646p, now could be like a buying opportunity.

Don’t expect instant relief. Glaxo will return to full health but faces serious challenges, notably with bestselling asthma blockbuster Advair, with sales of this generically challenged drug expected to fall from £4.2bn to as little as £300m over the next five year.

Finding equally lucrative replacements will take time. But the 5.46% yield should help soothe investor nerves until cost-savings and late stage pipeline drugs drive up earnings per share from 2016.

My Aim Is Pru

China and the other major emerging markets may be slowing but that doesn’t seem to have hurt Prudential (LSE: PRU).

First-quarter figures from its Asia Life division saw annual premium equivalent up 28% to £681m, the 22nd consecutive quarter of growth. New business profit grew 22% to £309m.

Profits in Asia have more than doubled over the past five years, compensating for sluggishness in Western markets.

Asian countries combine youthful demographics with low state welfare and sickness provision, which encourages the newly wealthy middle class to buy their own insurance rather than relying on the State to provide.

And Prudential is still performing pretty decently in its more mature US and UK markets.

Its stock isn’t cheap, having leapt 200% in five years. It now trades at 17 times earnings and yields just 2.15%, but you pay top dollar for a top performer like this one.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Harvey Jones has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

The market is wrong about this FTSE 250 stock. I’m buying it in April

Stephen Wright thinks investors should look past a 49% decline in earnings per share and consider investing in a FTSE…

Read more »

Black father and two young daughters dancing at home
Investing Articles

1 FTSE 250 stock I own, and 1 I’d love to buy

Our writer explains why she’s eyeing up this FTSE 250 growth phenomenon, and may buy more shares in this property…

Read more »